We are live on ! Find out more
ALT icon

Altimmune
ALT

118 hedge funds and large institutions have $375M invested in Altimmune in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 30 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $27.5M | Put options by funds: $7.92M

67% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 15

60% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 30

39% more capital invested

Capital invested by funds: $269M → $375M (+$106M)

11.69% more ownership

Funds ownership: 70.98% → 82.66% (+12%)

8% more funds holding

Funds holding: 109 → 118 (+9)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
118
Holders Change
+9
Holders Change %
+8.26%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
25
Increased
48
Reduced
30
Closed
15
Calls
$27.5M
Puts
$7.92M
Net Calls
+$19.6M
Net Calls Change
+$20.2M

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$26.4M
2
TCM
Tang Capital Management
California
+$9.93M
3
MWNA
Marshall Wace North America
New York
+$9.63M
4
AAP
Ardsley Advisory Partners
Connecticut
+$8.83M
5
LGM
Logos Global Management
California
+$8.51M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$15.4M
2
Capital World Investors
Capital World Investors
California
-$6.82M
3
Marshall Wace
Marshall Wace
United Kingdom
-$5.47M
4
Norges Bank
Norges Bank
Norway
-$3.19M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
DA
26
DCF Advisers
Connecticut
$2.71M +$1.14M +93,450 +64%
PHP
27
Parkman Healthcare Partners
Connecticut
$1.98M -$304K -25,000 -13%
Rafferty Asset Management
28
Rafferty Asset Management
New York
$1.86M -$212K -17,444 -10%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.82M +$320K +26,332 +20%
ACP
30
Acuta Capital Partners
California
$1.7M +$1.82M +150,000 New
Millennium Management
31
Millennium Management
New York
$1.56M +$1.68M +138,254 New
KCM
32
Knoll Capital Management
Florida
$1.5M +$1.01M +82,978 +166%
BWCS
33
Beirne Wealth Consulting Services
Connecticut
$1.49M -$22.3K -1,830 -1%
Principal Financial Group
34
Principal Financial Group
Iowa
$1.28M -$24.1K -1,982 -2%
Citigroup
35
Citigroup
New York
$1.23M -$2.03M -166,894 -60%
HT
36
HAP Trading
New York
$1.18M +$1.27M +104,491 New
UBS Group
37
UBS Group
Switzerland
$1.15M +$822K +67,557 +198%
Charles Schwab
38
Charles Schwab
California
$1.11M -$1.39M -114,295 -54%
State Board of Administration of Florida Retirement System
39
State Board of Administration of Florida Retirement System
Florida
$970K +$1.04M +85,759 New
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$967K -$901K -74,125 -46%
VOYA Investment Management
41
VOYA Investment Management
Georgia
$920K +$834K +68,560 +536%
ECM
42
ExodusPoint Capital Management
New York
$841K +$763K +62,717 +539%
Group One Trading
43
Group One Trading
Illinois
$787K +$33.4K +2,747 +4%
Norges Bank
44
Norges Bank
Norway
$765K -$3.19M -262,200 -80%
SSA
45
Schonfeld Strategic Advisors
New York
$754K +$810K +66,600 New
Squarepoint
46
Squarepoint
New York
$685K +$611K +50,256 +485%
PC
47
PointState Capital
New York
$679K -$486K -40,000 -40%
EMG
48
ETF Managers Group
New Jersey
$664K +$633K +52,012 New
DekaBank Deutsche Girozentrale
49
DekaBank Deutsche Girozentrale
Germany
$626K +$608K +50,000 New
JP Morgan Chase
50
JP Morgan Chase
New York
$617K +$490K +40,316 +282%
1
2
3 4 5

ALT Hedge Fund Activity: Q3 2021 in Review

118 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q3 2021, worth a combined $375M — up 39% from $269M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ALT positions and 15 closed out — a net gain of 10 holders — while 48 added to existing stakes and 30 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $26.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $15.4M sold.

  • 118 institutional investors held Altimmune (ALT) as of Q3 2021, up from 109 in Q2 2021.
  • Funds reported $375M of Altimmune stock for Q3 2021, up 39% quarter-over-quarter.
  • 25 funds opened new Altimmune positions in Q3 2021 and 15 closed out, a net change of +10 holders.
  • The largest Altimmune buyer in Q3 2021 was Avidity Partners Management, an estimated $26.4M added.
  • The largest Altimmune seller in Q3 2021 was Point72 Asset Management, an estimated $15.4M sold.

Based on aggregated 13F filings for Q3 2021.